Xbrane Biopharma AB (STU:7XB)
€ 0.0239 0.0132 (123.36%) Market Cap: 26.11 Mil Enterprise Value: 34.57 Mil PE Ratio: 0 PB Ratio: 0.97 GF Score: 48/100

Xbrane Biopharma at redeye investor forum Malmo 2021 Transcript

Dec 09, 2021 / NTS GMT
Release Date Price: €1.25 (-1.11%)
Unidentified Participant

So we have with us today Anette from (multiple speakers).

Anette Lindqvist
Xbrane Biopharma AB - CFO & Head of IR

So good evening everyone. My name is Anette Lindqvist (technical difficulty) today to present Xbrane Biopharma to you all, a company that I hadn't even heard of some years back. Having spent most of my career in the life science sector and more specifically with big pharma, I was determined to work as a consultant by moving back to Sweden from the UK. (technical difficulty) is back.

I read an article about Xbrane. (technical difficulty) after when I head out to restart, I did some proper research and spoke to former colleagues in the industry and was surprised by how many actually knew about Xbrane. Second, I was intrigued by the many positives I heard. Amazing company, great people, exciting times. And today, I'm here to present this company to you.

And whilst there are many reasons why Xbrane is interesting, there are three things that I would like you to (technical difficulty). The first one is that Xbrane

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot